Cargando…

Clinical Determinants of Quality of Life in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-Heart Failure With Preserved Ejection Fraction Registry

Detalles Bibliográficos
Autores principales:	Seo, Masahiro, Watanabe, Tetsuya, Yamada, Takahisa, Yano, Masamichi, Hayashi, Takaharu, Nakagawa, Akito, Nakagawa, Yusuke, Tamaki, Shunsuke, Yasumura, Yoshio, Sotomi, Yohei, Hikoso, Shungo, Nakatani, Daisaku, Fukunami, Masatake, Sakata, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561243/ https://www.ncbi.nlm.nih.gov/pubmed/35861075 http://dx.doi.org/10.1161/CIRCHEARTFAILURE.122.009789

Ejemplares similares

The clinical relevance of quality of life in heart failure patients with preserved ejection fraction
por: Seo, Masahiro, et al.
Publicado: (2022)

Prognostic significance of serum chloride level in heart failure patients with preserved ejection fraction
por: Seo, Masahiro, et al.
Publicado: (2022)

Sex Differences in Heart Failure With Preserved Ejection Fraction
por: Sotomi, Yohei, et al.
Publicado: (2021)

Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60%
por: Nakagawa, Akito, et al.
Publicado: (2022)

Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction
por: Sotomi, Yohei, et al.
Publicado: (2021)

Relation of left atrial overload indices with prognostic endpoints in heart failure and preserved ejection fraction
por: Hoshida, Shiro, et al.
Publicado: (2022)

Right Ventricular Dimension for Heart Failure With Preserved Ejection Fraction Involving Right Ventricular-Vascular Uncoupling
por: Nakagawa, Akito, et al.
Publicado: (2022)

Prognostic significance of dipstick proteinuria in heart failure with preserved ejection fraction: insight from the PURSUIT-HFpEF registry
por: Oeun, Bolrathanak, et al.
Publicado: (2021)

Prognostic relevance of elevated plasma osmolality on admission in acute decompensated heart failure with preserved ejection fraction: insights from PURSUIT-HFpEF registry
por: Nakagawa, Akito, et al.
Publicado: (2021)

Minimal subphenotyping model for acute heart failure with preserved ejection fraction
por: Sotomi, Yohei, et al.
Publicado: (2022)

Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT‐HFpEF registry
por: Nishino, Masami, et al.
Publicado: (2021)

Prognostic Importance of Pulmonary Arterial Capacitance in Acute Decompensated Heart Failure With Preserved Ejection Fraction
por: Nakagawa, Akito, et al.
Publicado: (2021)

Impact of Sex in Left Atrial Indices for Prognosis of Heart Failure with Preserved Ejection Fraction
por: Hoshida, Shiro, et al.
Publicado: (2022)

Prognostic Significance of Serum Cholinesterase Level in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Registry
por: Seo, Masahiro, et al.
Publicado: (2019)

Diastolic index as a short-term prognostic factor in heart failure with preserved ejection fraction
por: Hoshida, Shiro, et al.
Publicado: (2020)

Distinctive prognostic factor of heart failure with preserved ejection fraction stratified with admission blood pressure
por: Nakagawa, Akito, et al.
Publicado: (2021)

Change in Nutritional Status during Hospitalization and Prognosis in Patients with Heart Failure with Preserved Ejection Fraction
por: Sunaga, Akihiro, et al.
Publicado: (2022)

Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction
por: Nishino, Masami, et al.
Publicado: (2022)

Combination of Neutrophil‐to‐Lymphocyte and Platelet‐to‐Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients With Acute Decompensated Heart Failure With Preserved Left Ventricular Ejection Fraction: A Multicenter Study
por: Tamaki, Shunsuke, et al.
Publicado: (2022)

Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model
por: Sotomi, Yohei, et al.
Publicado: (2023)

Time-sensitive prognostic performance of an afterload-integrated diastolic index in heart failure with preserved ejection fraction: a prospective multicentre observational study
por: Hoshida, Shiro, et al.
Publicado: (2022)

Impact of admission hyperglycaemia on clinical outcomes in non‐diabetic heart failure with preserved ejection fraction
por: Yano, Masamichi, et al.
Publicado: (2021)

High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction
por: Yano, Masamichi, et al.
Publicado: (2021)

Study protocol for the PURSUIT-HFpEF study: a Prospective, Multicenter, Observational Study of Patients with Heart Failure with Preserved Ejection Fraction
por: Suna, Shinichiro, et al.
Publicado: (2020)

Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
por: Sunaga, Akihiro, et al.
Publicado: (2022)

Prognostic impact of Clinical Frailty Scale in patients with heart failure with preserved ejection fraction
por: Sunaga, Akihiro, et al.
Publicado: (2021)

Left atrial pressure overload and prognosis in elderly patients with heart failure and preserved ejection fraction: a prospective multicenter observational study
por: Hoshida, Shiro, et al.
Publicado: (2021)

Considerable scatter in the relationship between left atrial volume and pressure in heart failure with preserved left ventricular ejection fraction
por: Hoshida, Shiro, et al.
Publicado: (2020)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Relationships of Atrial Fibrillation at Diagnosis and Type of Atrial Fibrillation During Follow-up With Long-Term Outcomes for Heart Failure With Preserved Ejection Fraction
por: Nakatani, Daisaku, et al.
Publicado: (2022)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction
por: Tamaki, Shunsuke, et al.
Publicado: (2020)

Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction
por: Guazzi, Marco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_njtj7e44vt1voeiri5i15sisf7